Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pluri Inc.PSTI · Entity 7728 | Director | September 10, 2020 | September 10, 2020 |
| Scinai Immunotherapeutics Ltd.SCNI · Entity 8547 | Director | June 16, 2026 | June 18, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pluri Inc.
Report date September 10, 2020 · Filed September 10, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table I · non-derivative | Direct | 82,569 |
Reported balance
After 2020-09-10 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2020-09-10 · Grant · Acquired 20,000 · Balance 82,569 F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2: The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter. F3: Such number of shares of common stock have been adjusted to reflect the reverse stock split that occurred on July 25, 2019. |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of the Issuer's common stock.
F2: The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter.
F3: Such number of shares of common stock have been adjusted to reflect the reverse stock split that occurred on July 25, 2019.
Scinai Immunotherapeutics Ltd.
Report date June 16, 2026 · Filed June 18, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 120,000,000 |
Reported balance
After 2026-06-16 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 120,000,000 · Balance 120,000,000 F1: The Ordinary Shares are no par value per share, and are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares. F2: Includes 120,000,000 Ordinary Shares represented by restricted share units granted on June 16, 2026, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares are no par value per share, and are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares.
F2: Includes 120,000,000 Ordinary Shares represented by restricted share units granted on June 16, 2026, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Jun 18, 2026 18:51 UTC | Scinai Immunotherapeutics Ltd. SCNI · Entity 8547 | GrantOrdinary Shares | 120,000,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-26-003261 · zk2635578.xml · nonDerivative · entry 1 GERMAIN MARK · CIK 0001195498 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 120,000,000 F1 · security: The Ordinary Shares are no par value per share, and are represented by American Depositary Shares, each of which currently represents four thousand Ordinary Shares. F2 · shares: Includes 120,000,000 Ordinary Shares represented by restricted share units granted on June 16, 2026, which vest in three equal annual installments thereafter, subject to the Reporting Person's continued service through such dates. Read SEC document |
| September 10, 2020 Filed Sep 10, 2020 21:12 UTC | Pluri Inc. PSTI · Entity 7728 | GrantRestricted Stock Units | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-20-026095 · ownership.xml · nonDerivative · entry 1 GERMAIN MARK · CIK 0001195498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,569 F1 · security: Each RSU represents a contingent right to receive one share of the Issuer's common stock. F2 · date: The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter. F3 · balance_after: Such number of shares of common stock have been adjusted to reflect the reverse stock split that occurred on July 25, 2019. Read SEC document |
| December 19, 2018 Filed Dec 20, 2018 21:27 UTC | Pluri Inc. PSTI · Entity 7728 | GrantCommon Stock | 49,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-18-003193 · zk1822397.xml · nonDerivative · entry 2 GERMAIN MARK · CIK 0001195498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 625,694 F2 · date: The shares vest as follows: 12.5% on the 27 month anniversary of the date of grant and the remaining shares vest in 7 equal installments every 3 months thereafter. Read SEC document |
| December 19, 2018 Filed Dec 20, 2018 21:27 UTC | Pluri Inc. PSTI · Entity 7728 | GrantCommon Stock | 62,625 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-18-003193 · zk1822397.xml · nonDerivative · entry 1 GERMAIN MARK · CIK 0001195498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 576,569 F1 · date: The shares vest as follows: 25% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 6 equal installments every 3 months thereafter. Read SEC document |
| March 16, 2018 Filed Mar 19, 2018 21:08 UTC | Pluri Inc. PSTI · Entity 7728 | SaleCommon Stock | 11,640 | $1.48 | $17,227.20 |
DisclosureSEC source: 0001178913-18-000898 · zk1821378.xml · nonDerivative · entry 2 GERMAIN MARK · CIK 0001195498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 513,944 Read SEC document |
| March 15, 2018 Filed Mar 19, 2018 21:08 UTC | Pluri Inc. PSTI · Entity 7728 | SaleCommon Stock | 34,233 | $1.48 | $50,664.84 |
DisclosureSEC source: 0001178913-18-000898 · zk1821378.xml · nonDerivative · entry 1 GERMAIN MARK · CIK 0001195498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 525,584 Read SEC document |
| March 14, 2018 Filed Mar 15, 2018 21:12 UTC | Pluri Inc. PSTI · Entity 7728 | SaleCommon Stock | 23,818 | $1.50 | $35,727.00 |
DisclosureSEC source: 0001178913-18-000854 · zk1821367.xml · nonDerivative · entry 1 GERMAIN MARK · CIK 0001195498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 559,817 Read SEC document |
| December 14, 2017 Filed Dec 14, 2017 22:08 UTC | Pluri Inc. PSTI · Entity 7728 | GrantCommon Stock | 131,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-17-003395 · zk1720902.xml · nonDerivative · entry 1 GERMAIN MARK · CIK 0001195498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 583,635 F1 · date: The shares vest as follows: 12.5% on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter. Read SEC document |
| December 29, 2016 Filed Dec 29, 2016 21:07 UTC | Pluri Inc. PSTI · Entity 7728 | GrantCommon Stock | 65,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001178913-16-007188 · zk1619332.xml · nonDerivative · entry 1 GERMAIN MARK · CIK 0001195498 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 452,635 F1 · date: The shares vest as follows: 25% after 6 months from grant and the remaining shares vest in 6 equal installments every 3 months thereafter. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.